|
2024-11-12 |
2024-11-08 |
VP
Vente planifiée
|
Conner Edward R.
Chief Medical Officer
Dirigeant
|
2 117
-100.0%
15,00
31 755 USD
|
2 117
-100.0%
|
15,00
|
31 755 USD
|
|
|
2024-10-31 |
2024-10-29 |
V
Vente
|
BVF PARTNERS L P/IL
|
64 617
-26.8%
14,30
924 023 USD
|
64 617
-26.8%
|
14,30
|
924 023 USD
|
|
|
2024-10-31 |
2024-10-29 |
V
Vente
|
BVF PARTNERS L P/IL
|
396 963
-22.5%
14,30
5 676 571 USD
|
396 963
-22.5%
|
14,30
|
5 676 571 USD
|
|
|
2024-10-31 |
2024-10-29 |
V
Vente
|
BVF PARTNERS L P/IL
|
538 420
-23.1%
14,30
7 699 406 USD
|
538 420
-23.1%
|
14,30
|
7 699 406 USD
|
|
|
2024-10-30 |
2024-10-28 |
VP
Vente planifiée
|
Conner Edward R.
Chief Medical Officer
Dirigeant
|
2 673
-100.0%
15,00
40 095 USD
|
2 673
-100.0%
|
15,00
|
40 095 USD
|
|
|
2024-09-20 |
2024-09-19 |
VP
Vente planifiée
|
Person Julie
CHIEF ADMINISTRATIVE OFFICER
Dirigeant
|
9 497
-100.0%
14,29
135 685 USD
|
9 497
-100.0%
|
14,29
|
135 685 USD
|
|
|
2024-09-20 |
2024-09-19 |
VP
Vente planifiée
|
Conner Edward R.
Chief Medical Officer
Dirigeant
|
4 790
-100.0%
15,00
71 850 USD
|
4 790
-100.0%
|
15,00
|
71 850 USD
|
|
|
2024-09-20 |
2024-09-18 |
VP
Vente planifiée
|
Person Julie
CHIEF ADMINISTRATIVE OFFICER
Dirigeant
|
503
-100.0%
14,00
7 042 USD
|
503
-100.0%
|
14,00
|
7 042 USD
|
|
|
2024-06-28 |
2024-06-26 |
VP
Vente planifiée
|
Person Julie
CHIEF ADMINISTRATIVE OFFICER
Dirigeant
|
10 000
-100.0%
12,46
124 569 USD
|
10 000
-100.0%
|
12,46
|
124 569 USD
|
|
|
2024-06-10 |
2024-06-07 |
V
Vente
|
Dittman Jennifer
Chief Development Oper Officer
Dirigeant
|
494
-100.0%
14,17
7 000 USD
|
494
-100.0%
|
14,17
|
7 000 USD
|
|
|
2024-05-22 |
2024-05-20 |
V
Vente
|
Dittman Jennifer
Chief Development Oper Officer
Dirigeant
|
1 042
-100.0%
14,00
14 588 USD
|
1 042
-100.0%
|
14,00
|
14 588 USD
|
|
|
2024-05-22 |
2024-05-20 |
V
Vente
|
Dittman Jennifer
Chief Development Oper Officer
Dirigeant
|
1 042
-100.0%
14,00
14 588 USD
|
1 042
-100.0%
|
14,00
|
14 588 USD
|
|
|
2024-05-20 |
2024-05-16 |
VP
Vente planifiée
|
Dittman Jennifer
Chief Development Oper Officer
Dirigeant
|
23 578
-100.0%
14,04
331 066 USD
|
23 578
-100.0%
|
14,04
|
331 066 USD
|
|
|
2024-05-10 |
2024-05-09 |
VP
Vente planifiée
|
Holles Natalie C.
CEO
Administrateur exécutif
|
20 222
-1.6%
12,18
246 300 USD
|
20 222
-1.6%
|
12,18
|
246 300 USD
|
|
|
2024-05-10 |
2024-05-09 |
VP
Vente planifiée
|
Holles Natalie C.
CEO
Administrateur exécutif
|
20 222
-1.6%
12,18
246 300 USD
|
20 222
-1.6%
|
12,18
|
246 300 USD
|
|
|
2024-04-15 |
2024-04-11 |
VP
Vente planifiée
|
Holles Natalie C.
CEO
Administrateur exécutif
|
13 558
-1.1%
12,19
165 214 USD
|
13 558
-1.1%
|
12,19
|
165 214 USD
|
|
|
2024-04-08 |
2024-04-04 |
VP
Vente planifiée
|
Person Julie
CHIEF ADMINISTRATIVE OFFICER
Dirigeant
|
1 107
-100.0%
10,00
11 070 USD
|
1 107
-100.0%
|
10,00
|
11 070 USD
|
|
|
2023-12-07 |
2023-12-05 |
VP
Vente planifiée
|
Conner Edward R.
Chief Medical Officer
Dirigeant
|
4 790
-100.0%
10,03
48 062 USD
|
4 790
-100.0%
|
10,03
|
48 062 USD
|
|
|
2023-12-07 |
2023-12-05 |
VP
Vente planifiée
|
Person Julie
Chief Administrative Officer
Dirigeant
|
12 863
-100.0%
10,30
132 484 USD
|
12 863
-100.0%
|
10,30
|
132 484 USD
|
|
|
2022-12-22 |
2022-12-20 |
A
Achat
|
BVF PARTNERS L P/IL
Actionnaire important
|
9 597
+4.1%
4,11
39 430 USD
|
9 597
+4.1%
|
4,11
|
39 430 USD
|
|
|
2022-12-22 |
2022-12-20 |
A
Achat
|
BVF PARTNERS L P/IL
Actionnaire important
|
87 831
+5.2%
4,11
360 862 USD
|
87 831
+5.2%
|
4,11
|
360 862 USD
|
|
|
2022-12-22 |
2022-12-20 |
A
Achat
|
BVF PARTNERS L P/IL
Actionnaire important
|
116 635
+5.3%
4,11
479 207 USD
|
116 635
+5.3%
|
4,11
|
479 207 USD
|
|
|
2022-09-21 |
2022-09-19 |
A
Achat
|
ORBIMED ADVISORS LLC
Administrateur non-exécutif
Actionnaire important
|
300 000
+5.5%
17,00
5 100 000 USD
|
300 000
+5.5%
|
17,00
|
5 100 000 USD
|
|
|
2022-09-21 |
2022-09-19 |
A
Achat
|
Bonita David P
Administrateur non-exécutif
Actionnaire important
|
300 000
+5.5%
17,00
5 100 000 USD
|
300 000
+5.5%
|
17,00
|
5 100 000 USD
|
|
|
2022-09-19 |
2022-09-19 |
A
Achat
|
Atlas Venture Fund XI, L.P.
Actionnaire important
|
300 000
+3.0%
17,00
5 100 000 USD
|
300 000
+3.0%
|
17,00
|
5 100 000 USD
|
|
